成人弥漫性胶质瘤分子亚型GWAS鉴定D2HGDH和FAM20C变异
该研究按IDH突变、TERT启动子突变和1p/19q共缺失将胶质瘤分为分子亚型,对发现集1320例胶质瘤和1889例对照、验证集799例胶质瘤和808例对照进行GWAS。按亚型分析后发现D2HGDH、FAM20C及RTEL1附近区域与特定分子亚型相关。
要点
- 按分子亚型行GWAS可发现与特定胶质瘤亚型相关的胚系变异。
- D2HGDH区域变异与IDH突变型胶质瘤全基因组显著相关。
- RTEL1附近GMEB2区域变异与IDH野生型胶质瘤全基因组显著相关。
核心结论
- 按分子亚型行GWAS识别出2个新区域及RTEL1附近一个候选独立区域,与特定胶质瘤分子亚型相关。
研究设计与样本
- 发现集含1320例胶质瘤和1889例对照,验证集含799例胶质瘤和808例对照。
- 按IDH突变、TERT启动子突变和1p/19q共缺失组合将胶质瘤分为分子亚型。
- 对发现集和验证集行逻辑回归检验变异与各亚型的关联,随后行荟萃分析,全基因组P值阈值5×10-8。
主要发现
- IDH突变型胶质瘤中,2号染色体D2HGDH基因内或附近9个变异达全基因组显著,最显著为rs5839764,荟萃P=2.82×10-10。
- 按1p/19q共缺失分层,IDH突变非共缺失胶质瘤中D2HGDH一个变异达全基因组显著,rs1106639,荟萃P=4.96×10-8。
- 按TERT突变分层,IDH突变、TERT突变且1p/19q共缺失胶质瘤中7号染色体FAM20C附近一个变异达全基因组显著,rs111976262,荟萃P=9.56×10-9。
关键数值与推荐
- 全基因组显著性阈值定为5×10-8。
- IDH突变型胶质瘤D2HGDH最显著变异rs5839764的荟萃P=2.82×10-10。
- IDH突变非共缺失胶质瘤D2HGDH变异rs1106639的荟萃P=4.96×10-8。
- IDH突变、TERT突变且1p/19q共缺失胶质瘤FAM20C附近变异rs111976262的荟萃P=9.56×10-9。
- IDH野生型胶质瘤GMEB2附近最显著变异rs4809313的荟萃P=2.60×10-10。
临床怎么用
- 研究提示胶质瘤胚系易感性与分子亚型相关,但尚未提供可直接用于临床筛查或分型的阈值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Twenty-five germline variants are associated with adult diffuse glioma, and some of these variants have been shown to be associated with particular subtypes of glioma. We hypothesized that additional germline variants could be identified if a genome-wide association study (GWAS) were performed by molecular subtype. METHODS: A total of 1320 glioma cases and 1889 controls were used in the discovery set and 799 glioma cases and 808 controls in the validation set. Glioma cases were classified into molecular subtypes based on combinations of isocitrate dehydrogenase (IDH) mutation, telomerase reverse transcriptase (TERT) promoter mutation, and 1p/19q codeletion. Logistic regression was applied to the discovery and validation sets to test for associations of variants with each of the subtypes. A meta-analysis was subsequently performed using a genome-wide P-value threshold of 5 × 10-8. RESULTS: Nine variants in or near D-2-hydroxyglutarate dehydrogenase (D2HGDH) on chromosome 2 were genome-wide significant in IDH-mutated glioma (most significant was rs5839764, meta P = 2.82 × 10-10). Further stratifying by 1p/19q codeletion status, one variant in D2HGDH was genome-wide significant in IDH-mutated non-codeleted glioma (rs1106639, meta P = 4.96 × 10-8). Further stratifying by TERT mutation, one variant near FAM20C (family with sequence similarity 20, member C) on chromosome 7 was genome-wide significant in gliomas that have IDH mutation, TERT mutation, and 1p/19q codeletion (rs111976262, meta P = 9.56 × 10-9). Thirty-six variants in or near GMEB2 on chromosome 20 near regulator of telomere elongation helicase 1 (RTEL1) were genome-wide significant in IDH wild-type glioma (most significant was rs4809313, meta P = 2.60 × 10-10). CONCLUSIONS: Performing a GWAS by molecular subtype identified 2 new regions and a candidate independent region near RTEL1, which were associated with specific glioma molecular subtypes.
引用
- Eckel-Passow JE, Drucker KL, Kollmeyer TM, et al. Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20C. Neuro Oncol. 2020. PMID: 32386320. doi:10.1093/neuonc/noaa117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。